Molecular Genetic Tests for FLT3, NPM1, and CEBPA in Acute Myeloid Leukemia
Patients with acute myeloid leukemia (AML) and a normal karyotype constitute the single largest cytogenetic group of AML. It is important to identify prognostic markers that predict patients’ outcome more precisely. The presence of mutations in FLT3 (FMS-like tyrosine kinase 3), NPM1 (Nucleophosmin), and CEBPA (CCAAT/enhancer-binding protein alpha) genes hold prognostic significance in patients with AML and normal cytogenetics. Therefore, mutation identification may help to optimize therapeutic approaches in this group of patients. Polymerase chain reaction (PCR)-based fragment length analysis for mutations in FLT3 and NPM1 has been shown to be a fast and sensitive method, while nucleotide sequencing represents a gold standard for CEBPA heterogeneous mutational screening. We describe both fragment length assay and sequencing methods for mutational analysis of these three genes.
Key wordsAcute myeloid leukemia (AML) FLT3 NPM1 CEBPA PCR Capillary electrophoresis DNA sequencing Mutational detection
The authors wish to thank Dr. Stephen Dlouhy for his review of the manuscript.
- 1.Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trail: the medical research council adult and children’s leukaemia working parties. Blood 92:2322–2333PubMedGoogle Scholar
- 2.Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354–365PubMedCrossRefGoogle Scholar
- 6.Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, IARC, pp 120–122Google Scholar
- 10.Whitman SP, Ruppert AS, Radmacher MD, Mrózek K, Paschka P, Langer C et al (2008) FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications. Blood 111:1552–1559PubMedCrossRefGoogle Scholar
- 16.Hendricks-Taylor L, Bachinski LL, Siciliano MJ, Fertitta A, Trask B, de Jone P et al (1992) The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13 and related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14:12–17PubMedCrossRefGoogle Scholar